TY - JOUR
T1 - IgG4-related diseases: State of the art on clinical practice guidelines
AU - Iaccarino, Luca
AU - Talarico, Rosaria
AU - Scirè, Carlo Alberto
AU - Amoura, Zahir
AU - Burmester, Gerd
AU - Doria, Andrea
AU - Faiz, Karim
AU - Frank, Charissa
AU - Hachulla, Eric
AU - Hie, Miguel
AU - Launay, David
AU - Montecucco, Carlomaurizio
AU - Monti, Sara
AU - Mouthon, Luc
AU - Tincani, Angela
AU - Toniati, Paola
AU - van Hagen, Pieter Martin
AU - van Vollenhoven, Ronald F.
AU - Bombardieri, Stefano
AU - Mueller-Ladner, Ulf
AU - Schneider, Matthias
AU - Smith, Vanessa
AU - Cutolo, Maurizio
AU - Mosca, Marta
AU - Alexander, Tobias
PY - 2019/1/1
Y1 - 2019/1/1
N2 - Immunoglobulin G4-related diseases (IgG4-RD) are a group of chronic relapsing-remitting inflammatory conditions, characterised by tissue infiltration with lymphocytes and IgG4-secreting plasma cells, fibrosis and a usually favourable response to steroids. In this narrative review, we summarise the results of a systematic literature research, which was performed as part of the European Reference Network ReCONNET, aimed at evaluating existing clinical practice guidelines (CPGs) and recommendations in IgG4-RD. From 167 publications initially obtained from a systematic literature search, only one was identified as a systematic multispecialist, evidence-based, consensus guidance statement on diagnosis and treatment of IgG4-RD, which may be recommended for use as CPG in IgG4-RD. With the recognition of a limited evidence based in this increasingly recognised disease, the group discussion has identified the following unmet needs: lack of shared classification criteria, absence of formal guidelines on diagnosis, no evidence-based therapeutic recommendations and lack of activity and damage indices. Areas of unmet needs include the difficulties in diagnosis, management and monitoring and the scarcity of expert centres.
AB - Immunoglobulin G4-related diseases (IgG4-RD) are a group of chronic relapsing-remitting inflammatory conditions, characterised by tissue infiltration with lymphocytes and IgG4-secreting plasma cells, fibrosis and a usually favourable response to steroids. In this narrative review, we summarise the results of a systematic literature research, which was performed as part of the European Reference Network ReCONNET, aimed at evaluating existing clinical practice guidelines (CPGs) and recommendations in IgG4-RD. From 167 publications initially obtained from a systematic literature search, only one was identified as a systematic multispecialist, evidence-based, consensus guidance statement on diagnosis and treatment of IgG4-RD, which may be recommended for use as CPG in IgG4-RD. With the recognition of a limited evidence based in this increasingly recognised disease, the group discussion has identified the following unmet needs: lack of shared classification criteria, absence of formal guidelines on diagnosis, no evidence-based therapeutic recommendations and lack of activity and damage indices. Areas of unmet needs include the difficulties in diagnosis, management and monitoring and the scarcity of expert centres.
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85060282316&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/30729031
U2 - https://doi.org/10.1136/rmdopen-2018-000787
DO - https://doi.org/10.1136/rmdopen-2018-000787
M3 - Review article
C2 - 30729031
SN - 2056-5933
VL - 4
SP - e000787
JO - RMD OPEN
JF - RMD OPEN
IS - Suppl 1
M1 - e000787
ER -